| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
|
Egorin, Merrill J.
|
|
2001
|
47 |
4 |
p. 291-302
|
artikel
|
| 2 |
|
Morgan Jr, Robert J.
|
|
2000
|
47 |
4 |
p. 327-332
|
artikel
|
| 3 |
|
Kawanishi, Kunihiro
|
|
2000
|
47 |
4 |
p. 303-308
|
artikel
|
| 4 |
|
Ramu, Avner
|
|
2001
|
47 |
4 |
p. 338-346
|
artikel
|
| 5 |
|
Malingré, Mirte M.
|
|
2001
|
47 |
4 |
p. 347-354
|
artikel
|
| 6 |
|
Shamash, J.
|
|
2001
|
47 |
4 |
p. 370-372
|
artikel
|
| 7 |
|
Guemei, Aida A.
|
|
2001
|
47 |
4 |
p. 283-290
|
artikel
|
| 8 |
|
Zhou, Shufeng
|
|
2001
|
47 |
4 |
p. 319-326
|
artikel
|
| 9 |
|
Fyfe, D.
|
|
2001
|
47 |
4 |
p. 333-337
|
artikel
|
| 10 |
|
Tentori, Lucio
|
|
2001
|
47 |
4 |
p. 361-369
|
artikel
|
| 11 |
|
van Zuylen, Lia
|
|
2001
|
47 |
4 |
p. 309-318
|
artikel
|
| 12 |
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A
|
Malingré, Mirte M.
|
|
2001
|
47 |
4 |
p. 347-354
|
artikel
|
| 13 |
A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule
|
Fyfe, D.
|
|
2001
|
47 |
4 |
p. 333-337
|
artikel
|
| 14 |
Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study
|
Shamash, J.
|
|
2001
|
47 |
4 |
p. 370-372
|
artikel
|
| 15 |
Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy
|
Morgan Jr, Robert J.
|
|
2001
|
47 |
4 |
p. 327-332
|
artikel
|
| 16 |
Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters
|
Kawanishi, Kunihiro
|
|
2001
|
47 |
4 |
p. 303-308
|
artikel
|
| 17 |
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components
|
Tentori, Lucio
|
|
2001
|
47 |
4 |
p. 361-369
|
artikel
|
| 18 |
Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan
|
Guemei, Aida A.
|
|
2001
|
47 |
4 |
p. 283-290
|
artikel
|
| 19 |
In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac
|
Zhou, Shufeng
|
|
2001
|
47 |
4 |
p. 319-326
|
artikel
|
| 20 |
Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles
|
van Zuylen, Lia
|
|
2001
|
47 |
4 |
p. 309-318
|
artikel
|
| 21 |
Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1
|
Egorin, Merrill J.
|
|
2001
|
47 |
4 |
p. 291-302
|
artikel
|
| 22 |
PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential
|
Della Torre, Paola
|
|
2001
|
47 |
4 |
p. 355-360
|
artikel
|
| 23 |
The enhancement of riboflavin-mediated photo-oxidation of doxorubicin by histidine and urocanic acid
|
Ramu, Avner
|
|
2001
|
47 |
4 |
p. 338-346
|
artikel
|
Tijdschrift beschrijving